Literature DB >> 26457356

Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients.

Nancy M Joseph1, David A Solomon, Norma Frizzell, Joseph T Rabban, Charles Zaloudek, Karuna Garg.   

Abstract

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome is an autosomal dominant syndrome that results from mutations in the fumarate hydratase (FH) gene. Patients with HLRCC are at risk for smooth muscle tumors of the uterus and skin as well as renal tumors. The renal cell carcinomas associated with HLRCC are usually high stage at presentation, aggressive, and have poor clinical outcomes. Therefore these patients and family members would benefit from early identification and appropriate surveillance. In small studies, HLRCC-associated uterine leiomyomas have been noted to display characteristic morphologic features including eosinophilic cytoplasmic inclusions, prominent eosinophilic nucleoli, and perinucleolar halos. Limited data suggest that positive staining for 2-succinocysteine (2SC) and loss of staining for FH by immunohistochemistry (IHC) can help with identification of HLRCC. The aim of this study was to evaluate the ability of morphology and IHC for FH and 2SC to help identify HLRCC in young patients with uterine smooth muscle tumors. We identified 194 evaluable uterine leiomyomas from women less than 40 years of age. We found FH gene aberrations by mutation analysis in 5 cases, a 2.6% incidence. Of these 5 cases, 4 displayed the characteristic morphologic features outlined above, whereas 1 did not. All 5 tumors with FH gene abnormalities showed positive staining for 2SC, whereas no FH gene aberrations were found in the 2SC-negative cases. Loss of FH staining was seen in 2 of the 5 cases, 1 with frameshift mutation and the other with homozygous deletion, whereas the remaining 3 cases with missense FH gene mutations were FH positive. Our study shows that morphologic features can be helpful for detection of HLRCC in uterine leiomyomas, although they may not be present in every case. IHC for 2SC and FH can be helpful: presence of positive staining for 2SC is sensitive and specific for detection of FH gene aberrations, whereas loss of staining for FH is specific but not sufficiently sensitive, as cases with missense mutations in the FH gene can show retained staining.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26457356     DOI: 10.1097/PAS.0000000000000520

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

1.  Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.

Authors:  Chisato Ohe; Steven C Smith; Deepika Sirohi; Mukul Divatia; Mariza de Peralta-Venturina; Gladell P Paner; Abbas Agaimy; Mitual B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Maurizio Colecchia; Eva Compérat; Isabela Werneck da Cunha; Jonathan I Epstein; Anthony J Gill; Ondřej Hes; Michelle S Hirsch; Wolfram Jochum; Lakshmi P Kunju; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Gabriella Nesi; Adeboye O Osunkoya; Maria M Picken; Priya Rao; Victor E Reuter; Paulo Guilherme de Oliveira Salles; Luciana Schultz; Satish K Tickoo; Scott A Tomlins; Kiril Trpkov; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

2.  Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.

Authors:  Steven C Smith; Kiril Trpkov; Ying-Bei Chen; Rohit Mehra; Deepika Sirohi; Chisato Ohe; Andi K Cani; Daniel H Hovelson; Kei Omata; Jonathan B McHugh; Wolfram Jochum; Maurizio Colecchia; Mitual Amin; Mukul K Divatia; Ondřej Hes; Santosh Menon; Isabela Werneck da Cunha; Sergio Tripodi; Fadi Brimo; Anthony J Gill; Adeboye O Osunkoya; Cristina Magi-Galluzzi; Mathilde Sibony; Sean R Williamson; Gabriella Nesi; Maria M Picken; Fiona Maclean; Abbas Agaimy; Liang Cheng; Jonathan I Epstein; Victor E Reuter; Satish K Tickoo; Scott A Tomlins; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2016-11       Impact factor: 6.394

3.  Two Subtypes of Atypical Leiomyoma: Clinical, Histologic, and Molecular Analysis.

Authors:  Julianne M Ubago; Qing Zhang; Julie J Kim; Beihua Kong; Jian-Jun Wei
Journal:  Am J Surg Pathol       Date:  2016-07       Impact factor: 6.394

4.  Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei.

Authors:  Qing Zhang; Kate Poropatich; Julianne Ubago; Jia Xie; Xiuhua Xu; Norma Frizzell; Julie Kim; Beihua Kong; Jian-Jun Wei
Journal:  Int J Gynecol Pathol       Date:  2018-09       Impact factor: 2.762

Review 5.  [Hereditary renal tumors: More common than expected?].

Authors:  A Agaimy; A Hartmann
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

6.  Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases.

Authors:  Markku Miettinen; Anna Felisiak-Golabek; Bartosz Wasag; Magdalena Chmara; Zengfeng Wang; Ralf Butzow; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

Review 7.  Altered metabolite levels in cancer: implications for tumour biology and cancer therapy.

Authors:  Lucas B Sullivan; Dan Y Gui; Matthew G Vander Heiden
Journal:  Nat Rev Cancer       Date:  2016-09-23       Impact factor: 60.716

Review 8.  Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma.

Authors:  Veronica K Y Cheung; Anthony J Gill; Angela Chou
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 9.  The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.

Authors:  Inga-Marie Schaefer; Jason L Hornick; Judith V M G Bovée
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

10.  Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening.

Authors:  Lisa Siegler; Ramona Erber; Stefanie Burghaus; Tobias Brodkorb; David Wachter; Nafisa Wilkinson; James Bolton; Helen Stringfellow; Florian Haller; Matthias W Beckmann; Arndt Hartmann; Abbas Agaimy
Journal:  Virchows Arch       Date:  2018-01-13       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.